ARCHIVES

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

This article is from The Cancer Letter archive.

Vol. 01 No. 25 | June 20, 1975

Download PDF Visit The Full Archive

Related Articles

NCI Director Declines To Fund P-4 Breast Cancer Chemoprevention Trial.

June 22, 2007

NCI Intramural Budget: Well-Funded Labs, High Costs, Or Deceiving Appearances?

April 21, 1995

Sponsors Wanted: FDA Offers Incentives For Pediatric Oncology Drug Development.

March 10, 2000

FDA Approves Treatment For Late-Stage Cervical Cancer

June 30, 2006

Chabner Object To Yarbro’s Remarks On Federal Role In Clinical Research

April 15, 1983

Severe Shortages Of Many Cancer Drugs Affecting Practices

November 19, 2010